PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30161272-9	2019	miR-133a suppression accelerated transforming growth factor-beta1 (TGF-beta1)-induce EMT, as evidenced by upregulation of E-cadherin, and downregulation of N-cadherin, vimentin, and Slug.	mir-133a	0-8	transforming growth factor beta 1	Homo sapiens	33-65	
31511493-4	2019	Our data show that miR-133a was significantly upregulated by TGF-beta1 in a time- and concentration-dependent manner.	mir-133a	19-27	transforming growth factor beta 1	Homo sapiens	61-70	
31511493-5	2019	Surprisingly, miR-133a inhibits TGF-beta1-induced myofibroblast differentiation whereas miR-133a inhibitor enhances TGF-beta1-induced myofibroblast differentiation.	mir-133a	14-22	transforming growth factor beta 1	Homo sapiens	32-41	
31511493-5	2019	Surprisingly, miR-133a inhibits TGF-beta1-induced myofibroblast differentiation whereas miR-133a inhibitor enhances TGF-beta1-induced myofibroblast differentiation.	mir-133a	88-96	transforming growth factor beta 1	Homo sapiens	116-125	
31511493-6	2019	Interestingly, quantitative proteomics analysis indicates that miR-133a attenuates myofibroblast differentiation via targeting multiple components of TGF-beta1 profibrogenic pathways.	mir-133a	63-71	transforming growth factor beta 1	Homo sapiens	150-159	
31511493-7	2019	Western blot analysis confirmed that miR-133a down-regulates TGF-beta1-induced expression of classic myofibroblast differentiation markers such as alpha-smooth muscle actin (alpha-SMA), connective tissue growth factor (CTGF) and collagens.	mir-133a	37-45	transforming growth factor beta 1	Homo sapiens	61-70	
31511493-10	2019	Together, our study identified TGF-beta1-induced miR-133a as an anti-fibrotic factor.	mir-133a	49-57	transforming growth factor beta 1	Homo sapiens	31-40	
30161272-9	2019	miR-133a suppression accelerated transforming growth factor-beta1 (TGF-beta1)-induce EMT, as evidenced by upregulation of E-cadherin, and downregulation of N-cadherin, vimentin, and Slug.	mir-133a	0-8	transforming growth factor beta 1	Homo sapiens	67-76	
30161272-10	2019	Of contrast, miR-133a overexpression blocked TGF-beta1-induce EMT by altering these factors.	mir-133a	13-21	transforming growth factor beta 1	Homo sapiens	45-54	
30086463-0	2018	MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-beta/Smad3 signaling pathway.	mir-133a	0-8	transforming growth factor beta 1	Homo sapiens	90-98	
30086463-7	2018	Furthermore, we verified that overexpression of miR-133a suppressed biological behaviour of HCC through TGF-beta/Smad3 signaling pathway.	mir-133a	48-56	transforming growth factor beta 1	Homo sapiens	104-112